Is Aurora Cannabis Inc. (TSX:ACB) Still Undervalued Right Now?

Aurora Cannabis Inc. (TSX:ACB) stock is up over 30% in the past month but it is still attractive in September.

| More on:

Aurora Cannabis (TSX:ACB) stock dropped 3.02% on September 5. Aurora boasted the most volume on the TSX along with its peers Canopy Growth and Aphria. Cannabis stocks have been a bright spot on the TSX over the past week as the index has suffered from volatility amid intense trade negotiations between the United States and Canada.

Shares of Aurora have still climbed 34% over the past month. Still, for some onlookers Aurora’s performance may seem muted considering its production capacity and overall size. Dilution has been a factor, as Aurora made two massive acquisitions in 2018 in a bid to secure and increase its market share. The aggressive tactics appear to have paid off in the short term going by its fiscal 2018 third-quarter earnings release.

Grams sold surged 107.2% year over year to 1.35 million, while revenues climbed 211.1% to $16.1 million. This, of course, is still dwarfed by its market share, which is now over $8 billion. Aurora is expected to release its fiscal 2018 fourth-quarter results in late September. This will be a key measuring stick for investors as recreational legalization looms. Is Aurora still a solid buy before its earnings release?

On September 4, Aurora announced that it had closed its $200 million debt facility with Bank of Montreal. The facility also includes an option to increase the total to $250 million following the October 17, 2018, legalization date. This will give Aurora added flexibility as the legalization rollout is bound to ramp up demand in the coming months.

Some of Aurora’s acquisition targets have also begun to bear fruit for the company as the summer winds to a close. On August 22, Aurora announced that it had received Health Canada authorization to produce cannabis softgel capsules at its Aurora Vie facility in Pointe-Claire, Quebec. Production has already begun in partnership with Montreal-based manufacturer Capcium Inc., which specializes in high-volume softgel encapsulation.

Perhaps the most exciting acquisition in the near term is Aurora’s stake in Alcanna (TSX:CLIQ), an Edmonton-based alcohol and soon-to-be cannabis retailer. Alcanna has rights to open cannabis stores under the brand name Aurora Cannabis across Canada. As the largest private sector liquor retailer in Canada, Alcanna has a vast footprint that is highly desirable.

The move by the new Ontario government to privatize cannabis retail could present a huge opportunity for Aurora and Alcanna. Reports indicated that Alcanna immediately began probing the new PC government after its election. Although the province has yet to release a structure for wholesale cannabis retail, investors should be confident that Alcanna will be aggressive in its pursuit of a footprint in Canada’s most populous province.

As of close on September 5, Aurora stock is priced at $8.68, nearly half of the value it reached at its all-time high back in late January. Some of its smaller acquisitions are starting to pay off while its larger splashes should see returns when surging demand begins to put the squeeze on lesser players in the industry. Aurora appears well prepared for the rollout, and the stock remains a nice speculative buy today.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ambrose O'Callaghan has no position in any of the stocks mentioned.

More on Investing

edit Safety First illustration
Dividend Stocks

3 of the Safest Dividend Stocks in Canada

These three dividend stocks are all high-quality companies with defensive operations, making them some of the safest investments in Canada.

Read more »

data analyze research
Bank Stocks

Better Buy: Royal Bank Stock or Bank of Nova Scotia?

Bank stocks appear cheap after the latest plunge. Is Royal Bank or Bank of Nova Scotia a buy today?

Read more »

A person builds a rock tower on a beach.
Dividend Stocks

3 Stocks to Anchor Your Portfolio in a Rocky Market

Three stocks are solid anchors in any portfolio today for their outperformance in a weak market and defiance of the…

Read more »

Metals and Mining Stocks

Better Metals Buy: Gold Stocks vs. Lithium Stocks

Gold is the evergreen choice as a hedge against inflation and weak markets. In contrast, battery metals may offer unique…

Read more »

Man making notes on graphs and charts
Bank Stocks

TD Bank Stock: A TSX Top Pick Amid U.S. Banking Rout?

TD Bank (TSX:TD) stock could prove a worthy bet for brave investors who aren't fearful over the recent wave of…

Read more »

edit Sale sign, value, discount
Tech Stocks

2 Cheap Tech Stocks to Buy Right Now

Many tech stocks offer exceptional returns compared to other stock sectors when the market is bullish. You can add to…

Read more »

money cash dividends
Dividend Stocks

3 Solid Dividend Stocks That Cost Less Than $30

Given their solid financials and healthy cash flows, the following under-$30 dividend stocks are a good buy in this volatile…

Read more »


Is Now the Right Time to Buy Fortis Stock?

Fortis stock looks cheap today. Should you buy now or wait?

Read more »